Device Trial Radar · NCT07240649
Emerging Indications for Hyperbaric Oxygen Treatment
Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Dec 2035
Study completion Dec 2035
Sponsor
- Lead sponsor
- Jay C. Buckey Jr.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Dartmouth College
- First posted
- Nov 21, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.
Conditions
- Post-COVID-19 Condition
- Ulcerative Colitis
- Crohn Disease
- Calciphylaxis
- Frostbite
- Acute COVID-19
- Pyoderma Gangrenosum
- Pterygium
- Hypospadias
- Head Trauma
- Pneumatosis Intestinalis
- Ischemic Bowel
- Raynaud Syndrome
- Malignant Otitis Externa
- Nonarteritic Anterior Ischemic Optic Neuropathy
- Central Retinal Vein Occlusion
- Femoral Head Necrosis
- Invasive Fungal Infection
- Chronic Anal Fissure
- Vasculitic Ulcer
- Graft-vs-Host Disease
- Decubitus Ulcer
- Greater Trochanteric Pain Syndrome
- Rectovaginal Fistula
- Pouchitis
- Tinnitus
- Clostridium Enterocolitis
- Branch Retinal Artery Occlusion
- Axonotmesis
- Multiple Sclerosis
- Inclusion Body Myositis
- Epidermolysis Bullosa (EB)
- Osteonecrosis
- Ulcer Ischemic
- Avascular Necrosis of Bone
- Prosthesis Related Infections
- Facial Filler Injections
- Cystitis Chronic
- Ligament Injury
- Anastomosis, Leaking
- Cartilage Injury
Interventions
Hyperbaric oxygen treatment (HBOT)Device
Hyperbaric oxygen refers to oxygen given at pressures higher than atmospheric pressure (higher than 1.4 ATA) in pressurized chamber.
100% OxygenDrug
Receiving 100% oxygen as part of HBOT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Quality of Life EuroQOL EQ-5D-5L QuestionnaireTime frame: Within one week of starting HBO2 and within one week of ending HBO2 treatment
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.